Chronix Biomedicals Serum DNA Assays Detect Early-Stage Breast Cancer
Chronix Biomedical announced publication of a study that supports the utility of its serum DNA blood tests for the early and accurate detection of breast cancer.
Read MoreMonth: March 2010
Quest Diagnostics OVA1 Blood Test Available for Pre-surgical Ovarian Cancer Evaluation
OVA1, the first blood test cleared by the FDA for aiding in the pre-surgical evaluation of a woman’s ovarian mass for cancer, is now available nationally through Quest Diagnostics.
Read More
Clinical Utility of DiagnoCure’s PCA3 Prostate Cancer Marker Confirmed
DiagnoCure Inc announced that the clinical utility of the PROGENSA PCA3 test, developed and commercialized by its partner Gen-Probe, was confirmed in two large worldwide studies, conducted in a subset of patients in GlaxoSmithKline’s REDUCE trial of dutasteride.
Read MoreNew Genetic Test Helps Predict Frequency Of Genital Herpes Outbreaks
Molecular dermatology research and development innovator DermaGenoma Inc has released the HerpesDX genetic test for frequent Genital herpes. The new screening test will help doctors assess patients risk for developing frequent Genital Herpes (HSV-2) outbreaks.
Read More